4 research outputs found
A prospective follow up of serum uric acid levels in school children
Na dvije kontrole, u razmaku od tri godine, odreĀÄena je razina mokraÄne kiseline u serumima 381 uÄenika (starih prosjeÄno 11,4 odnosno 14,3 godine). Uz to su ispitivani i brojni drugi parametri (broj eritrocita, MCV, MCH, MCHC, trigliceridi, holesterol itd.), od kojih je analiziran odnos mokraÄne kiseline i tjelesne težine. Analiziran je i odnos navedenih parametara prema istim, dobivenim u ranijem radu, u kom su ispitivana djeca stara 6,4 godine (prvi razred osnovne Å”kole). NaÄen je statistiÄki znaÄajan porast razine mokraÄne kiseline u djeÄaka starih 14,4 godine te pojava korelacije razine mokraÄne kiseline i tjelesne težine u oba spola (r = 0,35) te dobi (nasuprot manjku te povezanosti u mlaÄih dobnih skupina djece od 6,4, odnosno 11,4 godine starosti).In 381 children serum uric acid levels were measured at the age of 11.4 and 14.3. Numerous other parameters were also measured (as the erythrocytes, MCV, MCH, MCHC, tryglicerides, cholesterol etc) but only the relation among uric acid levels and body weight was analysed. The relation of these parameters and the data we have got in our previous work (in first grade elementary school children aged 6.4 years) is also discussed. We found significant increase of uric acid levels in boys aged 14.4 and an association between the serum uric acid levels and the body weight appears in both sexes at this age (r=0.35). (Opposite to the lack of this association in younger children, aged 6.4, and 11.4)
A prospective follow up of serum uric acid levels in school children
Na dvije kontrole, u razmaku od tri godine, odreĀÄena je razina mokraÄne kiseline u serumima 381 uÄenika (starih prosjeÄno 11,4 odnosno 14,3 godine). Uz to su ispitivani i brojni drugi parametri (broj eritrocita, MCV, MCH, MCHC, trigliceridi, holesterol itd.), od kojih je analiziran odnos mokraÄne kiseline i tjelesne težine. Analiziran je i odnos navedenih parametara prema istim, dobivenim u ranijem radu, u kom su ispitivana djeca stara 6,4 godine (prvi razred osnovne Å”kole). NaÄen je statistiÄki znaÄajan porast razine mokraÄne kiseline u djeÄaka starih 14,4 godine te pojava korelacije razine mokraÄne kiseline i tjelesne težine u oba spola (r = 0,35) te dobi (nasuprot manjku te povezanosti u mlaÄih dobnih skupina djece od 6,4, odnosno 11,4 godine starosti).In 381 children serum uric acid levels were measured at the age of 11.4 and 14.3. Numerous other parameters were also measured (as the erythrocytes, MCV, MCH, MCHC, tryglicerides, cholesterol etc) but only the relation among uric acid levels and body weight was analysed. The relation of these parameters and the data we have got in our previous work (in first grade elementary school children aged 6.4 years) is also discussed. We found significant increase of uric acid levels in boys aged 14.4 and an association between the serum uric acid levels and the body weight appears in both sexes at this age (r=0.35). (Opposite to the lack of this association in younger children, aged 6.4, and 11.4)
Guidelines for treatment of atopic dermatitis
Atopijski dermatitis Äesta je, kroniÄno recidivirajuÄa upalna bolest kože karakterizirana složenom etiopatogenezom i raznolikim kliniÄkim fenotipom. KliniÄka slika može biti razliÄita, a bolest je obilježena ponavljajuÄim dermatitisom, izraženim svrbežom i znaÄajnim utjecajem na kvalitetu života oboljele osobe i cijele obitelji. Dijagnoza se postavlja na temelju kliniÄke slike prema standardiziranim dijagnostiÄkim kriterijima, a procjena težine bolesti prema standardiziranim instrumentima za procjenu težine bolesti. LijeÄenje treba prilagoditi svakom bolesniku, a cilj lijeÄenja je smanjiti simptome svrbeža, obnoviti oÅ”teÄenu kožnu barijeru, sprijeÄiti egzacerbaciju bolesti, sprijeÄiti odnosno lijeÄiti komplikacije i komorbiditete te smanjiti negativni utjecaj bolesti na kvalitetu života. ZahvaljujuÄi napretku u razumijevanju etiopatogeneze, terapijske moguÄnosti su zadnjih godina znaÄajno napredovale. Hrvatsko dermatoveneroloÅ”ko druÅ”tvo Hrvatskoga lijeÄniÄkog zbora predstavlja smjernice za dijagnostiku i lijeÄenje atopijskog dermatitisa. Smjernice su rezultat konsenzusa hrvatskih struÄnjaka za atopijski dermatitis koji su kritiÄki prouÄili mjerodavnu znanstvenu literaturu, koja se temelji na najboljim dokazima.Atopic dermatitis is a common, chronically recurrent inflammatory skin disease characterized by a complex etiopathogenesis and a variable clinical phenotype. The clinical presentation is heterogeneous, and the disease is characterized by a recurrent dermatitis, intense itching and a significant impact on the quality of life of patients and their family. The diagnosis is based on the clinical presentation according to the standardized diagnostic
criteria, while the assessment of disease severity of the disease is based on the standardized tools for disease severity assessment. Treatment should be tailored to each patient profile, and the goal of the treatment is focused on decreasing symptoms and renewing damaged skin barrier, preventing the exacerbation of the disease and preventing or treating the complications and comorbidities, and decreasing the negative influence of the disease on the patientās quality of life. Due to progress in understanding the etiopathogenesis, treatment options have significantly expanded in the past years. The Croatian Society of Dermatovenerology of the Croatian Medical Association is presenting guidelines for diagnosis and treatment of atopic dermatitis. These guidelines are the result of consensus of Croatian experts based on critical analysis of relevant, evidence-based scientific literature
Guidelines for treatment of atopic dermatitis
Atopijski dermatitis Äesta je, kroniÄno recidivirajuÄa upalna bolest kože karakterizirana složenom etiopatogenezom i raznolikim kliniÄkim fenotipom. KliniÄka slika može biti razliÄita, a bolest je obilježena ponavljajuÄim dermatitisom, izraženim svrbežom i znaÄajnim utjecajem na kvalitetu života oboljele osobe i cijele obitelji. Dijagnoza se postavlja na temelju kliniÄke slike prema standardiziranim dijagnostiÄkim kriterijima, a procjena težine bolesti prema standardiziranim instrumentima za procjenu težine bolesti. LijeÄenje treba prilagoditi svakom bolesniku, a cilj lijeÄenja je smanjiti simptome svrbeža, obnoviti oÅ”teÄenu kožnu barijeru, sprijeÄiti egzacerbaciju bolesti, sprijeÄiti odnosno lijeÄiti komplikacije i komorbiditete te smanjiti negativni utjecaj bolesti na kvalitetu života. ZahvaljujuÄi napretku u razumijevanju etiopatogeneze, terapijske moguÄnosti su zadnjih godina znaÄajno napredovale. Hrvatsko dermatoveneroloÅ”ko druÅ”tvo Hrvatskoga lijeÄniÄkog zbora predstavlja smjernice za dijagnostiku i lijeÄenje atopijskog dermatitisa. Smjernice su rezultat konsenzusa hrvatskih struÄnjaka za atopijski dermatitis koji su kritiÄki prouÄili mjerodavnu znanstvenu literaturu, koja se temelji na najboljim dokazima.Atopic dermatitis is a common, chronically recurrent inflammatory skin disease characterized by a complex etiopathogenesis and a variable clinical phenotype. The clinical presentation is heterogeneous, and the disease is characterized by a recurrent dermatitis, intense itching and a significant impact on the quality of life of patients and their family. The diagnosis is based on the clinical presentation according to the standardized diagnostic
criteria, while the assessment of disease severity of the disease is based on the standardized tools for disease severity assessment. Treatment should be tailored to each patient profile, and the goal of the treatment is focused on decreasing symptoms and renewing damaged skin barrier, preventing the exacerbation of the disease and preventing or treating the complications and comorbidities, and decreasing the negative influence of the disease on the patientās quality of life. Due to progress in understanding the etiopathogenesis, treatment options have significantly expanded in the past years. The Croatian Society of Dermatovenerology of the Croatian Medical Association is presenting guidelines for diagnosis and treatment of atopic dermatitis. These guidelines are the result of consensus of Croatian experts based on critical analysis of relevant, evidence-based scientific literature